153 related articles for article (PubMed ID: 36273341)
1. Hydrolytically Stable and Cytotoxic [ONO
Pedko A; Rubanovich E; Tshuva EY; Shurki A
Inorg Chem; 2022 Nov; 61(44):17653-17661. PubMed ID: 36273341
[TBL] [Abstract][Full Text] [Related]
2. Phenolato Ti(IV) hexacoordinate complexes for anticancer chemotherapy: enhancement of solubility, hydrolytic stability, and cytotoxicity.
Taha M; Tshuva EY
Dalton Trans; 2023 Jun; 52(22):7664-7672. PubMed ID: 37199994
[TBL] [Abstract][Full Text] [Related]
3. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
4. Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.
Meker S; Braitbard O; Margulis-Goshen K; Magdassi S; Hochman J; Tshuva EY
Molecules; 2015 Oct; 20(10):18526-38. PubMed ID: 26473816
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Pure Enantiomers of Titanium(IV) Complexes with Chiral Diaminobis(phenolato) Ligands and Their Biological Reactivity.
Miller M; Tshuva EY
Sci Rep; 2018 Jun; 8(1):9705. PubMed ID: 29946136
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of asymmetrical diaminobis(alkoxo)-bisphenol compounds and their C
Nahari G; Tshuva EY
Dalton Trans; 2021 May; 50(19):6423-6426. PubMed ID: 33949509
[TBL] [Abstract][Full Text] [Related]
7. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
van Rijt SH; Peacock AF; Johnstone RD; Parsons S; Sadler PJ
Inorg Chem; 2009 Feb; 48(4):1753-62. PubMed ID: 19146436
[TBL] [Abstract][Full Text] [Related]
8. Highly Effective and Hydrolytically Stable Vanadium(V) Amino Phenolato Antitumor Agents.
Reytman L; Braitbard O; Hochman J; Tshuva EY
Inorg Chem; 2016 Jan; 55(2):610-8. PubMed ID: 26699515
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic homoleptic Ti(iv) compounds of ONO-type ligands: synthesis, structures and anti-cancer activity.
Manne R; Miller M; Duthie A; Guedes da Silva MFC; Tshuva EY; Basu Baul TS
Dalton Trans; 2018 Dec; 48(1):304-314. PubMed ID: 30516219
[TBL] [Abstract][Full Text] [Related]
10. Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.
Meker S; Braitbard O; Hall MD; Hochman J; Tshuva EY
Chemistry; 2016 Jul; 22(29):9986-95. PubMed ID: 27320784
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and hydrolysis of trans-Ti(IV) complexes of salen ligands: structure-activity relationship studies.
Tzubery A; Tshuva EY
Inorg Chem; 2012 Feb; 51(3):1796-804. PubMed ID: 22220885
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs.
Ganot N; Briaitbard O; Gammal A; Tam J; Hochman J; Tshuva EY
ChemMedChem; 2018 Nov; 13(21):2290-2296. PubMed ID: 30203598
[TBL] [Abstract][Full Text] [Related]
15. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumoral Titanium
Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
[TBL] [Abstract][Full Text] [Related]
17. Monomeric Ti(iv)-based complexes incorporating luminescent nitrogen ligands: synthesis, structural characterization, emission spectroscopy and cytotoxic activities.
Khalil G; Orvain C; Fang L; Barloy L; Chaumont A; Gaiddon C; Henry M; Kyritsakas N; Mobian P
Dalton Trans; 2016 Nov; 45(47):19072-19085. PubMed ID: 27858023
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cells.
Meker S; Margulis-Goshen K; Weiss E; Braitbard O; Hochman J; Magdassi S; Tshuva EY
ChemMedChem; 2014 Jun; 9(6):1294-8. PubMed ID: 24677761
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative Activities of Diimine-Based Mixed Ligand Copper(II) Complexes.
Kordestani N; Rudbari HA; Fernandes AR; Raposo LR; Baptista PV; Ferreira D; Bruno G; Bella G; Scopelliti R; Braun JD; Herbert DE; Blacque O
ACS Comb Sci; 2020 Feb; 22(2):89-99. PubMed ID: 31913012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]